• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BXA:GR

0.120 EUR 0.0000.00%

As of 02:06:04 ET on 12/23/2014.

Snapshot for Lavipharm SA (BXA)

Open: 0.120 Day's Range: 0.120 - 0.120 Volume: 0
Previous Close: 0.120 52wk Range: 0.087 - 0.164 1-Yr Rtn: -16.67%

Stock Chart for BXA

No chart data available.
  • BXA:GR 0.120
  • 1D
  • 1M
  • 1Y
0.120
Interactive BXA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BXA

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 6.13
Shares Outstanding (M) 51.08
30 Day Average Volume 333
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (EUR) -
Dividend Ex-Date 06/05/2009
5 Year Dividend Growth -
Next Earnings Announcement 04/01/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BXA

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for BXA

Lavipharm S.A. develops, produces, promotes, trades, and distributes cosmetics and pharmaceuticals. The Company also represents overseas drug and cosmetics companies including Avon, Hoffman La Roche, Schering Plough, 3M, and Murdipharma.

Athanase LavidasChairman/CEOTania Panagiota VranopoulosDeputy CEO
Spyridon FotinosChief Scientific OfficerDimitra TsomokouFinance Director
More Company Profile & Key Executives for BXA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil